Can a 1,500-Patient biobank unlock the secrets of chronic pancreatitis?

NCT ID NCT07770412

NEW Not yet recruiting Knowledge-focused Sponsor: First People's Hospital of Hangzhou Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This observational study will follow 1,500 adults with chronic pancreatitis for several years, collecting health data and biological samples like blood, stool, and bile. The goal is to track how the disease changes over time, especially in those undergoing ERCP treatment, and to identify factors linked to complications or pancreatic cancer. By building a detailed biobank, researchers hope to improve future diagnosis and care for this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This research could lead to better ways to monitor chronic pancreatitis, predict complications, and improve treatment decisions for ERCP procedures.
What could go wrong: As an observational study, it cannot prove cause and effect. The findings may not apply to all patients, and long-term follow-up may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PANCREATITIS

Contacts and locations

Locations

First People's Hospital of Hangzhou

Hangzhou, Zhejiang, 310006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.